​​​​CALL ​ ​+1-888-511-8719



Purchase of the VascuWave™ Device
Physician Visit & 1st Month Medications
Initial Clinical Treatments
VascuWave™ Device Repeat Cycle
Monthly Medication Cost
Clinical Treatment Annual Followup
Clinical Treatment Repeat Cycle
Monthly Cost Over Device Life
VascuWave™ Monthly Savings
VascuWave™ Annual Savings

Costs Based On:

   + VascuWave™ Device has a 1 time purchase cost and will last 10 years (on average) with normal use and care.
   + Medication averages $300 per month and includes cost of initial physician exam for medication prescription.
   + In-clinic Treatment can last for 2 years with an annual maintenance session.
   + Lifetime savings based on 10 year average device life.

$2,995 one time
with 3 DAY, DISCRETE, free shipping​ 
investment ON VascuWave
​for a lifetime of Satisfaction

​Revealed the 10 benefits
of using VascuWave

  • 1
    Painless Solution To Sexual Dysfunction
  • 2
    In-Home​ Solution – Privacy​ of your own home
  • 3
    Non-Inva​​​​sive Procedure
  • 4
    Long Term Solution
  • 5
    Phone, Chat & Email SUPPORT with Patient Care Specialists
  • 6
    Regenerates nerves for increased sensitivity
  • 7
    ​Use in association with other treatment options
  • 8
    ​Works on Men and Women
  • 9
    2 Year Product warranty included for free
  • 10
    ​No risk to you - 180 day money back guarantee

Join the growing number of happy customers

Give yourself a gift with love

take a step to improve your life style

  • Enjoy and Improve your sex life
  • Enjoy a healthy relationship with your partner
  • ​Increase confidence
  • Improve your life style
  • Enjoy the gifts of sexual pleasure

Responsible for creating VascuWave 



Michael J. Dattoli, MD, is a board-certified radiation oncologist with well over two decades of brachytherapy experience and has performed thousands of prostate implant procedures. He is considered the foremost pioneer optimizing brachytherapy designs to maximize tumor eradication and minimize symptoms. He is a noted author and speaker in this complex field of medicine. Dr. Dattoli attended the University of California at Berkeley and was the Valedictorian of his class at Vassar College; he earned his medical degree at Mount Sinai School of Medicine, Radiation Oncology at New York University Medical Center, then distinguished himself at Memorial Sloan-Kettering Cancer Center and New York Hospital-Cornell University Medical Center, as the Special Fellow in Brachytherapy. Dr. Dattoli serves on multiple journal editorial review boards. Government appointments include “The Prostate Cancer Task Force” in Florida and consultant to the “Washington Oncology Roundtable Advisory Committee”. He was selected by the International Association of Oncologists as a Leading Physician of the World and top Brachytherapist.

Michael J. Dattoli - Co-Founder


Joseph M. Kaminski, MD, previously Senior Medical Staff at the National Cancer Institute at the National Institutes of Health, is a board-certified Radiation Oncologist who is internationally known for his work in accelerating the development of cancer therapeutics including normal tissue radioprotectors/mitigators, imaging techniques, and important interventional devices. He has authored more than 70 publications in peer reviewed journals and has served on multiple journal editorial boards. Dr. Kaminski has also held positions as a Lead Medical Officer at the Food and Drug Administration. He was also a medical officer at the National Institutes of Allergy and Infectious Diseases. He graduated with highest honors from Georgia Institute of Technology, one of the nation’s top bioengineering universities, and completed medical school at the Medical College of Georgia.

Joseph M. Kaminski - Co-Founder

Scientific Advisor

Dr. Stanislav Emelianov is a Joseph M. Pettit Endowed Chair, Georgia Research Alliance Eminent Scholar, and Professor of Electrical & Computer Engineering and Biomedical Engineering at the Georgia Institute of Technology. He is also appointed at Emory University School of Medicine where he is Professor of Radiology and is affiliated with Emory’s Winship Cancer Institute and other clinical units. Dr. Emelianov is an internationally recognized expert in biomedical imaging instrumentation and nanoagents for imaging and therapy. He is the author of over 500 publications including peer-reviewed research articles, invited reviews, book chapters, conference proceedings, and patents. In recognition of his contributions to the field, Dr. Emelianov was elected to the College of Fellows of the American Institute for Medical and Biological Engineering. He is past Vice-President for Ultrasonics of the IEEE Ultrasonics, Ferroelectrics and Frequency Control Society, and senior member of several professional organizations.

Dr. Stanislav Emelianov - Scientific Advisor

Scientific Advisor

Dr. Mechanick is Professor of Medicine and Medical Director of the Marie-Josee and Henry R.Kravis Center for Cardiovascular Health at Mount Sinai Heart, and in the Cardiovascular Institute and Division of Cardiology, and Director of Metabolic Support in the Division of Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai. He received his M.D. degree from the Icahn School of Medicine at Mount Sina. Dr. Mechanick authored over 300 publications in Endocrinology, Metabolism, and Nutrition Support. Dr. Mechanick co-edited Nutritional Strategies for theDiabetic and Prediabetic Patient, Power of Prevention: The Complete Guide to Lifelong Nutrition, Thyroid Cancer: From Emergent Biotechnology to Clinical Practice Guidelines, Molecular Nutrition. Dr. Mechanick was appointed as a member of the President’s Council on Fitness, Sports and Nutrition (PCFSN) and Science Board for 2010-2013. Dr. Mechanick also chairs the International Transcultural Diabetes Nutrition Algorithm Working Group.

Dr. Jeffrey Mechanick - Scientific Advisor

Scientific Advisor

Orhan H. Suleiman, MS, PhD, FAAPM, FHPS, has expertise encompassing a broad range of scientific and regulatory experience related to Food and Drug Administration (FDA) regulated medical products (drugs, medical devices, and biologics). He retired in November, 2014, from the United States FDA, after 37 years with the federal agency responsible for assuring the safety and efficacy of such products. At FDA he was the Senior Science Policy Advisor in the Office of New Drugs, where he was involved in many regulatory initiatives involving safety, human subject research, and inspections. He represented the FDA on a variety of domestic and international committees. He received his BS (1970) and MS (1972) degrees in Radiological Sciences from the University of Florida, and his Ph.D. (1989) from the Johns Hopkins School of Hygiene and Public Health. In 1998 he was appointed into FDA’s Senior Biomedical Research Service (SBRS), a select group of federal senior level scientists. In 1999 he was elected as a Fellow of the American Association of Physicists in Medicine (AAPM), served as president of the Baltimore Washington Chapter of the Health Physics Society (2006-7), and in 2013 he was also selected as a Fellow in the Health Physics Society. He is an Emeritus member of these societies as well as the Society of Nuclear Medicine and Molecular Imaging (SNMMI). He has authored over 50 formal publications in the scientific literature, and presented numerous times domestically and internationally on these topics.

Orhan H. Suleiman, MS, PhD, FAAPM, FHPS


What Have You got to Lose - START THE PROCESS NOW​​
​We are, so confident about  VascuWave, we​ ​offer ​100% money back guarantee​ for 180 days..

Money Back Guara​​​​ntee

​​​​180 day money back guarantee,

if not 100% satisfied


​2 year warranty against any manufacturing defects

Free Shipping

​​Free ​discrete shipping

within US 48 states

​​Your Satisfaction


​Better Business Bureau

​          Authorize Net        ​
​         Cleared      

​       PayPal Approved      

Guys Section
Gals Section